Technical
Channels

Drug Discovery

Drug Development

Drug Manufacturing

Drug Delivery

Clinical Trials

Regulatory and Legal

Alliances and Mergers

QA/QC and Compliance

Pharmaceutical Processing and Packaging

Change text size [+] [-]

Fluidigm Singapore Manufactures 250 Millionth Valve

Wednesday, September 02, 2009
 Email This |  Printer Friendly

Fluidigm has announced that its Singapore biochip factory has manufactured and shipped more than 250 million microscopic NanoFlex valves.

The valves stop or release the flow of liquids containing genetic samples and reagents in microfluidic chips. These chips are used by life science researchers to conduct endpoint, real-time and digital Polymerase Chain Reaction (PCR) analyses. These manufactured valves are small and precise and can isolate a single cell or DNA molecule, permitting researchers to detect the mutation of a cell into a cancerous state, earlier than standard techniques.


Share this:   Del.icio.us | 
Digital Edition



Singapore's Preclinical R&D industry should differentiate itself in Asia by competing on quality rather than on price.
Yes
No
View results


ABOUT PHARMA ASIA | FREE SUBSCRIPTION | CONTACT US

© 2010 Ten Alps Communications Asia. All rights reserved.
Use of this Web site is subjected to its Terms and Conditions of Use. View our Privacy Policy